Tilray Brands Inc vs Veeva Systems — how do they compare? Tilray Brands Inc trades at $3.6 (market cap $530.54M), while Veeva Systems trades at $285.1 (market cap $46.12B). The key difference: Veeva Systems is far larger — about 86.9× Tilray Brands Inc's market cap, and Veeva Systems is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and Veeva Systems for 5 Days on average.
| TLRY | VEEV | |
|---|---|---|
Market Cap | $530.54M | $46.12B |
Volume | 9,099,075 | 921,537 |
Sector | Health | Technology |
52-Week High | $21.00 | $299.10 |
52-Week Low | $3.57 | $151.43 |
Typical Hold Time | 31 Days | 5 Days |
Enterprise Value | $684.46M | $39.03B |
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $3.715, down 1.72% on the day and near its 52-week low, reflecting persistent bearish technical momentum. The company reported revenue of $821.31M in 2025 but a substantial net loss of -$2.19B, with negative cash flow from operations. Recent quarters show consistent earnings misses versus expectations, though analyst consensus suggests a high price target of $65.01 amid mixed sentiment.
The outlook remains challenged by profitability issues and high debt, but potential catalysts include U.S. cannabis regulatory changes. Investment opportunities hinge on speculative regulatory shifts, while risks include ongoing losses, competitive pressures, and reliance on financing activities to sustain operations.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →